Clinical trial Recruiting at 1 site Interventional Ages 65 and up

Exploring the effects of postbiotics on elderly hemodialysis patients

Official title: A Postbiotics Improves the Quality of Life and Nutritional Status in Elderly Hemodialysis Patients

Run by Peking University First Hospital · NCT06975995 · Data updated 2026-11-12

This study is testing if a new postbiotics product can improve the quality of life and nutrition for elderly patients on hemodialysis.

Quick facts

Study typeInterventional
Ages65 Years and up
SexAll
Enrollment60 (estimated)
SponsorPeking University First Hospital
Academic / other
Locations1 site (Beijing, Beijing Municipality)
StatusRecruiting
StartedAugust 1, 2024
Main results expectedDecember 2026
Study endsDecember 2026
Registry record updatedMay 16, 2025
Trial IDNCT06975995 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are elderly individuals aged 65 and older who have been on maintenance hemodialysis for at least six months.

Probably not a fit

Patients with recent gastrointestinal issues or conditions affecting oral feeding may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This trial investigates the impact of exogenous postbiotics on the quality of life and nutritional status of elderly patients undergoing hemodialysis. Participants aged 65 and older will be randomly assigned to receive either a postbiotics product or a placebo for 12 weeks, followed by a crossover period where the placebo group will receive the postbiotics. The study aims to assess changes in quality of life and nutrition through various indicators over the treatment period. It is a multicenter, prospective, open-label, randomized controlled trial designed to provide insights into the benefits of postbiotics for this vulnerable population.

Why it matters

Potential benefit: If successful, this study could significantly improve the quality of life and nutritional status of elderly patients on hemodialysis.

How similar studies have gone: While the specific use of postbiotics in this context is novel, similar studies have shown promising results in improving health outcomes in patients with chronic conditions.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Investigators must maintain a screening log of all potential study candidates that includes limited information about the potential candidate, date, and outcome of the screening process (e.g. enrolled into study, reason for ineligibility, or refused to participate). After signing an informed consent form, potential patients must meet all of the criteria:

1. Age ≥65 years.
2. Receiving maintenance hemodialysis therapy for at least 6 months.

Exclusion Criteria:

The following exclusion criteria must NOT be present for each subject:

1. Subjects with medical history that might affect oral feeding (e.g. intestinal obstruction, gastrointestinal bleeding, acute pancreatitis and accidental inhalation) within the last 1 month prior to screening.
2. Subjects with medical history that might affect gastrointestinal functions (e.g. inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), short bowel syndrome (SBS), et al.).
3. Subjects who cannot communicate and collaborate normally.

Where it's running

  • Peking UFH
    Beijing, Beijing Municipality, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.